Company
Adverum Biotechnologoes
Redefining sight for life.®
Also known as Adverum Biotechnologies, Adverum Biotechnologies, Inc.
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Legal name
- Adverum Biotechnologies, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Adverum Biotechnologies is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness.
Funding snapshot
- Total raised
- $199MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $128M2024-02-07
Funding rounds
- Round, 2024
- $128M2024-02-07, SEC form D sold, 20 investors
- Round, 2014
- $10M2014-08-05, SEC form D sold, 1 investor
- Round, 2014
- $55.1M2014-04-16, SEC form D sold, 45 investors
- Round, 2010
- $5.7M2010-09-07, SEC form D sold, 16 investors
Products
- Other
- Ixo-vec
Loading relationship preview